Eversept Partners, LP

Q4 2017 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Ron Rosenstraus - Chief Financial Officer
Location
New York, NY
Holdings as of
December 31, 2017
Value $
$150M
Num holdings
45
Date filed
11/8/2023, 01:26 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Next filing
Q1 2018 - Nov 8, 2023
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ron Rosenstraus Chief Financial Officer New York, United States 11/8/2023

Eversept Partners, LP ("Eversept") is filing this amendment primarily to correct our previous reporting of put and call option positions. In the Information Table in all reports on Form 13F filed from the fourth quarter of 2017 through the second quarter of 2023, Eversept had erroneously provided the requested information in columns 2-5 of the Information Table with respect to the put and call options themselves, rather than with respect to the securities underlying the options.